Sutro Biopharma Inc. (STRO)
undefined
undefined%
At close: undefined
2.12
0.47%
After-hours Dec 13, 2024, 07:42 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -106.79M -119.20M -105.54M -32.13M -55.74M -35.32M -19.69M 1.70M
Depreciation & Amortization 6.82M 5.69M 4.84M 4.30M 4.78M 4.54M 4.99M 5.66M
Stock-Based Compensation 24.91M 26.30M 23.24M 11.92M 10.31M 2.87M 1.39M 968.00K
Other Working Capital -10.23M 100.29M -12.61M -11.22M -20.45M 44.93M -25.03M -21.98M
Other Non-Cash Items -2.17M -13.65M 6.16M 606.00K 193.00K -517.00K 132.00K 98.00K
Deferred Income Tax - - 7.24M -41.01M -1.30M -1.50M 3.00M 80.00K
Change in Working Capital -34.38M 104.41M -17.62M -11.49M -23.26M 42.61M -26.90M -21.66M
Operating Cash Flow -111.62M 3.55M -81.68M -67.80M -65.02M 12.68M -37.07M -13.15M
Capital Expenditures -4.32M -7.86M -15.32M -7.13M -3.48M -1.56M -3.32M -4.39M
Acquisitions - 28.74M - - 47.65M - - 16.00K
Purchase of Investments -460.30M -216.67M -248.73M -130.74M -196.23M -81.46M -14.22M -52.30M
Sales Maturities Of Investments 460.69M 189.50M 166.73M 138.38M 148.58M 2.75M 50.06M 66.27M
Other Investing Acitivies - -28.73M 9.00K 89.00K -47.65M 80.00K 80.00K 16.00K
Investing Cash Flow -3.92M -35.02M -97.31M 604.00K -51.13M -80.19M 32.60M 9.59M
Debt Repayment -12.50M -9.38M - 15.00M -5.00M - 15.00M -
Common Stock Repurchased - - -7.00K - -327.00K - - -
Dividend Paid - - - - - - - -
Other Financial Acitivies 138.08M 1.42M 3.26M 2.83M 1.14M 86.35M -362.00K 177.00K
Financial Cash Flow 137.55M 48.31M 3.26M 269.25M -4.18M 170.78M 14.64M 177.00K
Net Cash Flow 22.01M 16.84M -175.74M 202.05M -120.34M 103.28M 10.17M -3.38M
Free Cash Flow -115.93M -4.31M -97.00M -74.93M -68.50M 11.13M -40.39M -17.55M